基于未折叠的蛋白质反应相关基因的低HER2乳腺癌预后模型的识别和验证

Yanjiao Zhao1, Yuanyuan Gao1, Hui Yan2

  • 1The Third Department of Medical Oncology, General Hospital of Ningxia Medical University, Xingqing District, Yinchuan, 750004, Ningxia, People's Republic of China.

Discover oncology
|October 14, 2025
PubMed
概括

这项研究确定了四个未折叠蛋白质响应 (UPR) 基因 (COPS5,DKC1,NOP56,EIF4G1),可预测 HER2 低乳腺癌的预后. 这些发现提供了对瘤微环境和潜在的免疫治疗策略的见解.